Purpose: To detect circulating retina-specific autoreactive CD4 + T-cells and antiretinal antibodies (ARA) in latent tuberculosis (TB)-associated uveitis or sarcoid uveitis patients. Methods: The presence of crude retinal extract (RE) autoreactive CD4 + T-cells was determined by a highly sensitive flowcytometric-based technique examining co-expression of CD25 and CD134 (OX40) on RE stimulated PBMC. The presence of ARA in available matched serum samples was assessed by indirect immunofluorescence. Results: No autoreactive CD4 + T-cells against RE could be detected in either latent TB-associated uveitis or sarcoid uveitis patients, while ARA were detected in the serum of the majority (5/6) of latent TBassociated uveitis and all (3/3) sarcoid uveitis patients. Conclusion: Even with the use of this highly sensitive flowcytometric technique circulating retinaspecific autoreactive CD4 + T-cells could not be detected. In contrast, ARA were detected in the majority of patients indicating an adaptive humoral immune response toward retinal antigens had occurred.
Tuberculosis (TB)-associated uveitis represents a major cause of uveitis, particularly in TB endemic countries. The pathophysiology of TB-associated uveitis is still incompletely understood. Ocular infection with Mycobacterium tuberculosis (Mtb) is a very rare condition that may cause uveitis when Mtb-bacilli invade the eye and consequently elicit local granulomatous inflammation. [1] [2] [3] In support of local ocular infection by Mtb, anti-tuberculosis therapy (ATT) can be very effective in TB-associated uveitis patients without systemic signs of TB, higher response rates have been witnessed in patients with a high QuantiFERON-TB Gold test (QFT) score. 4 However, the results were often inconclusive, better responses to ATT in combination with corticosteroids have been shown and a significant number of patients still need corticosteroid treatment after ATT, which may point to the involvement of other pathophysiological mechanisms as well. Several lines of evidence suggest that autoimmune reactions against retinal antigens might constitute part of the pathophysiology of uveitis, which may especially be relevant in the setting of latent TB-associated uveitis. [4] [5] [6] [7] [8] Autoreactive T-cells toward crude retinal extract (RE) have been found in vitreous samples from patients with TBassociated uveitis. 9 Yet, this study failed to identify RE autoreactive T-cells in paired peripheral blood samples, which was attributed to a presumed low-frequency of RE-specific T-cells in peripheral blood. 9 Alternatively, the sensitivity of the experimental approach (intracellular cytokine staining) might impede detection in this study. 9 Detection of peripheral T-cells with auto-reactivity toward retinal antigens is, however, necessary for a good understanding of the immunopathogenesis of TB-associated uveitis and subsequent treatment and thus warrants further study. 9 To detect retina-specific autoreactive T-cells in peripheral blood, we retrospectively examined induction of the activation markers CD25 (IL-2 Receptor-α) and CD134 (OX40) on the cell surface of CD4 + T-cells of patients with latent TBassociated uveitis upon stimulation with RE. This approach displays higher sensitivity than other techniques used to detect antigen-specific T-cell activation, including intracellular cytokine detection. 10, 11 The potential of this test has been shown for detecting latent TB infections by measuring specific T-cell recall responses to Mtb-specific peptides. 12 Therefore, stimulation experiments with Mtb purified protein derivative (PPD) served as a control in our study. Antiretinal autoantibodies (ARA) were previously found in TB-associated uveitis. 13 As the initiation of a humoral immune response may depend on T-cell help, we measured ARA in available paired serum samples. Outcomes of latent TB-associated uveitis patients were compared to those from patients with sarcoid uveitis as this disease shares multiple immunopathological features with TB and is sometimes clinically hard to distinguish from latent TB-associated uveitis. 8, 14, 15 
Material and Methods

Patients and Sample Collection
In this study, patients with latent TB-associated uveitis (n = 7) and sarcoid uveitis (n = 4) who visited the outpatient clinic of the department of Ophthalmology and Clinical Immunology of the Erasmus MC, University Medical Center, Rotterdam were included. All patients underwent a standardized uveitis work-up and full ophthalmological examination. 16 In patients with anterior uveitis and panuveitis, the human leukocyte antigen (HLA) B27 was determined. Patient characteristics are given in supplementary Table 1 .
Diagnosis of latent TB-associated uveitis was assigned after the exclusion of underlying systemic diseases and other causes of uveitis, a positive score (>0,35 IU/ml) in the QFT, and the absence of any signs suggesting active TB. The diagnosis of definite sarcoid uveitis was given after excluding other causes of uveitis and conformation by biopsy of an accessible inflammation site. Sarcoidosis patients included were QFT negative.
Blood samples were collected and peripheral blood mononuclear cells (PBMC) were isolated using a Ficoll (GE healthcare, Chicago, IL, USA) based density separation technique. Subsequently, PBMC were frozen until further analysis. Demographic data were collected at the time of sampling.
All subjects provided their written informed consent. The study was approved by the medical ethical committee of the Erasmus MC, University Medical Center, Rotterdam (protocol number MEC-2016-606) and in coherence with the tenets of the Declaration of Helsinki.
Retinal Extracts
Retina extract was prepared as described previously by Kuiper et al. 17 In brief, retina tissue was obtained from a postmortem eye without a history of intraocular inflammation or vitreoretinal disease. The retina was carefully dissected from the underlying pigment epithelium, homogenized in 500 µL phosphate-buffered saline (PBS) and subsequently centrifuged (10000 relative centrifugal force (RCF), 4°C, 30 min). The supernatant was carefully collected and heat-inactivated at 100°C for 7 min to neutralize endogenous tissue protease activity. Protein yield was assessed by colorimetric Bradford assay and the extract was aliquoted and stored at −80°C until further use.
Human Umbilical Vein Endothelial Cell Extracts
The human umbilical vein endothelial cell line (HUVEC) was cultured in the EBMTM-2 basal medium supplemented with EGMTM-2 SingleQuatsTM (Lonza, Basel, Switzerland) and penicillin and streptomycin (100 IU/ml; BioWhittaker, Verviers, Belgium). Cells were harvested by scraping, homogenized in 500 µL PBS containing the protease inhibitors prefabloc (Roche, Basel, Switzerland), α-prot (Roche), and sodium orthovanadate (Sigma-Aldrich, St. Louis, MO, USA), followed by three cycles of freeze-thawing and subsequently centrifuged (10000 RCF, 4°C, 30 min). The supernatant was carefully collected, protein yield was assessed by colorimetric Bradford assay and the extract was aliquoted and stored at −80°C until further use.
Detection of Antigen-Specific CD4 + T-Cells by Measurement of CD25/CD134 Co-Expression
Cryopreserved PBMC were thawed and suspended in RPMI-1640 (Gibco, Paisley, UK) culture medium supplemented with 10% fetal calf serum (Gibco), L-glutamine 2 mM (BioWhittaker), and penicillin and streptomycin (100 IU/ml; BioWhittaker). Cells were seeded onto 24-well plates, at 0.5 × 10 6 cells per well. For each assay, the following conditions were used: no exogenous stimulation (negative control), stimulation with 2,5 µg/ml phytohemagglutinin (PHA; positive control), RE or HUVEC protein lysate (irrelevant protein control) at final concentrations of 100-, 10-, or 1 µg/ml. As an antigen-specific positive control for the latent TBassociated uveitis patients, PBMC were stimulated with mycobacterium tuberculosis PPD (Statens Serum Institute, Copenhagen, Denmark) at a concentration of 4 µg/ml. Cells were stimulated for 48 h in a humidified 5% CO 2 incubator. Subsequently, 100 µl of cell suspension of each culture was stained for 15 min at room temperature (RT) with 20 μl of the antibody mixture provided in the Act-T4 Cell TM kit (CD3-PerCP-Cy5.5, CD4-FITC, CD25-APC, and CD134-PE; Cytognos, Salamanca, Spain), for better selection of the leukocyte population, 5 μl CD45-PO (Invitrogen Corporation, Carlsbad, CA, USA) was added to the antibody mix. Thereafter, erythrocytes were lysed with erythrocyte lyse-nonwash solution provided in the Act-T4 Cell TM kit following the manufactures instructions. Cells were measured using a BD FACSCanto TM (BD Biosciences, San Jose, CA, USA) cell analyzer. Flow-cytometric data were analyzed using the Infinicyt software (Cytognos).
Leukocytes were selected by CD45 vs side scatter, after which T-lymphocytes were identified using a CD3 vs side scatter gate, followed by a selection of CD3 + CD4 + T-cells, which were then analyzed for CD25 and CD134 coexpression. Gates for CD25 + and CD134 + were based upon a comparison of negative control (unstimulated) and positive control (PHA) stimulation. Results for induction of CD3 + CD4 + CD25 + CD134 + T-cells obtained upon stimulation with RE, HUVEC lysate or mycobacterium tuberculosis PPD were calculated as a stimulation index relative to maximal induction obtained with PHA (specific stimulus/PHA stimulus).
Detection of Antiretinal Antibodies by Indirect Immunofluorescence (IIF)
Serum ARA were determined as described previously. 16 In short, primate retinal tissue (EuroImmun, Lubeck, Germany) was incubated with patients' serum (1:100 dilution) for 30 min at RT. After washing with PBS 0.2% Tween, sections were incubated with goat anti-human IgA/G/M conjugated with fluorescein isothiocyanate (EuroImmun) for 30 min at RT. Sections were washed with PBS 0.2% Tween, embedded in glycerol and covered with a coverslip. Slides were analyzed using an AXIO Lab.A1 fluorescence microscope (Zeiss, Thornwood, NY, USA) and photographed at 200x and 400x magnification using a Nikon DS-Fi1 camera (Minato, Tokyo, Japan). Retinal tissue incubated with PBS or 1:100 diluted serum from a person negative for anti-nuclear antibodies (ANA) and ARA were used as negative controls. As positive controls, retinal tissue was incubated with either 1:100 diluted serum from an ANA positive person or 1:100 diluted serum from an ARA positive person. Sera from the included patients (1:80 dilution) were also analyzed for the presence of ANA by IIF using HEp-2 cells (Inova, San Diego, CA, USA) according to routine diagnostic protocols used in the laboratory medical immunology of the department of immunology within Erasmus MC. A positive staining of nuclei within the retinal tissue was scored as undetermined in case of a positive ANA result.
Statistics
All data analyses were performed in GraphPad Prism 5.0. Comparison between two groups was performed by an unpaired, two-tailed student's t-test. Correlations were calculated by pearson's correlation coefficient. A p-value < .05 was considered significant.
Results
Patients' Characteristics
The mean age of the latent TB-associated uveitis patients at the moment of blood sampling was 47 years (range 29-66 years) and 40 (range 29-51) for the sarcoid uveitis patients. The mean duration of uveitis was 5.5 years for the latent TBassociated uveitis group and 1.5 years for the sarcoid uveitis group. None of the latent TB-associated uveitis patients received immune suppressive therapy (IST) nor ATT within 3 months before study inclusion. From the ocular sarcoidosis patients, three did not receive IST within 3 months before study inclusion, while in one of the patients, IST (methotrexate) was started 1 month before blood drawing. For a detailed overview of all assessed individual patient characteristics, see supplementary Table 1 .
Detection of Antigen-Specific CD4 + T-Cells
In all patients tested, stimulation of PBMC with PHA resulted in clear activation of the CD4 + T-lymphocytes as evidenced by an increase of the CD4 + CD25 + CD134 + T-lymphocyte fraction. Yet, the increase in CD4 + CD25 + CD134 + T-lymphocytes was significantly (p < 0,05) lower in the latent TB-associated uveitis group than the sarcoid uveitis group (Figures 1 and 2a) . Moreover, in the latent TB-associated uveitis group the responsiveness of CD4+ T-lymphocytes to PHA correlated significantly (p < .05, r 2 = 0.63) with the observed response upon mycobacterium tuberculosis PPD stimulation (Figure 2b ). Six out of seven latent TB-associated uveitis patients responded to mycobacterium tuberculosis PPD stimulation with an induction of CD4 + CD25 + CD134 + population with a stimulation index of at least 0.05. This mycobacterium tuberculosis PPD stimulation index did not exceed 0.03 in the sarcoid uveitis group (Figure 3) . Stimulation with the different RE concentrations seemed to have a slight stimulatory effect on T-cells from 3 out of 7 latent TB-associated uveitis patients (Figure 4a ). Yet the same patients also responded to stimulation with HUVEC protein lysate, which served as irrelevant protein control ( Figure 4b ). Therefore, the T-cell responses observed to RE in these patients were considered a-specific.
Detection of Serum ARA
Serum for detection of ARA was available from six of the latent TB-associated uveitis patients and from three of the sarcoid uveitis patients. Five of the six latent TB-associated uveitis patients' sera revealed reactivity against retinal tissue. In one of these cases, positivity against retinal cell nuclei was observed in combination with ANA positivity and was therefore scored as undetermined. The other four positive latent TB-associated uveitis cases displayed reactivity of varying intensity (weak to strong) against retinal cell nuclei and/or the photoreceptor layer and the outer limiting membrane (OLM; Figure 5 ) and were ANA negative. Sera of all three sarcoid uveitis patients were ANA negative but did display reactivity against retinal cell nuclei with two sera also displaying reactivity against the photoreceptor layer and one also against the OLM. Retinal staining patterns are summarized in Table 1 .
Discussion
In this study, we used a sensitive flowcytometry-based assay to detect retina-autoreactive CD4 + T-cell responses. Yet, no retina-autoreactive CD4 + T-cells were found in peripheral blood of patients with latent TB-associated uveitis or sarcoid uveitis. In contrast, specific ARA were detected in the majority of latent TB-associated uveitis and sarcoid uveitis patients.
Retinal autoimmunity has been proposed in TB-associated uveitis for a while. 18, 19 Moreover, the development of anterior granulomatous uveitis has been described following Bacille-Calmette-Guérin (BCG) therapy for bladder carcinoma. This was associated with the presence of peripheral T-cells that The fact that retina-specific CD4 + T-cells could not be detected in our study is unlikely to be related to a generalized state of unresponsiveness, as PBMC from all patients responded to PHA stimulation and PBMC from 6 out of 7 latent TB-associated uveitis cases also responded to mycobacterium tuberculosis PPD stimulation. In addition, IFN-γ was detected in the culture supernatant of 3 out of 7 latent TB-associated uveitis cases after stimulation with PPD (data not shown). We can however not exclude the possibility that our RE isolation procedure resulted in the generation of heat-denatured proteins that might not be easily processed by antigen-presenting cells and subsequently presented to T-lymphocytes. The PHA response was however significantly lower in the latent TB-associated uveitis group, suggesting a certain level of T-cell unresponsiveness or exhaustion in comparison to sarcoid uveitis patients, even though a-specific and pathogen specific recall responses have been shown to be reduced in sarcoidosis patients. 20 This is further supported by the positive correlation between the mycobacterium tuberculosis PPD induced response and the PHA induced response observed in the latent TB-associated uveitis group.
There are several possibilities why retina-autoreactive CD4 + T-cells were not detected in the patient's blood samples. First, the number of circulating retina-autoreactive CD4 + T-cells might be extremely low in the blood of latent TB-associated uveitis patients and therefore too low for detection. This was also suggested by Tagirasa et al. who did find autoreactive T-cells toward RE in vitreous samples from TB-associated uveitis patients but not in matched peripheral blood samples. 9 Second, uveitis activity and limited patient inclusion might have contributed to our findings. In this study, only three out of the seven latent TB-associated uveitis and two out of the four sarcoid uveitis patients had active uveitis at the time of sampling. In contrast, previous studies that did find circulating autoreactive T-cells to specific retinal antigens or RE in patients with uveitis (e.g. sarcoidosis, Behçet disease, Vogt-Koyanagi-Harada syndrome, and birdshot chorioretinopathy) mostly included patients with active uveitis. 17, 21, 22 Moreover, the studies that did find circulating retina-autoreactive T-cells enrolled higher patient numbers but detected autoreactive T-cells only in part of the included patients. 17, 21, 22 Lastly, for this study, we used cryopreserved cells which might lead to suboptimal responses to certain stimuli in comparison to freshly isolated blood mononuclear cells. 23 Although autoreactive CD4 + T-cells against RE were not detected in peripheral blood of the latent TB-associated uveitis patients, we did detect serum ARA in 5/6 (83%) of these cases. This is at a higher prevalence than our group previously described in presumably healthy blood donors from the Netherlands (17%), 16 but also in Indonesian patients with uveitis in the setting of active TB (44%) or latent TB (37%). 13 The three sarcoid uveitis sera analyzed were all ARA positive (100%), indicative of an autoimmune component in these cases as well, yet without detectable retinaautoreactive T-cells in the peripheral blood. Serum antibodies to retinal antigens have been previously described in~44% of sarcoid uveitis patients. 24 Although there is no evidence that these ARA are pathogenic and may just reflect retinal damage their presence might support the occurrence of a T-cell dependent anti-retinal immune response in cases of TB-associated as well as sarcoid uveitis. Yet, we cannot exclude the possibility of a T-cell independent humoral immune response against retina antigens nor potential molecular mimicry as has been demonstrated to exist for mycobacterial heat-shock protein-65 and medium molecular weight neurofilament (NF-M). 25, 26 Discrepancies between autoantibody positivity and the absence of detectable circulating autoreactive T-cells have been observed in other disease entities as well, for instance in anti-Hu antibody-associated paraneoplastic neurological syndromes. 27 The high ARA prevalence observed in our current study might be an overestimation as the number of patients per uveitis group was small.
In conclusion, we were unable to demonstrate circulating autoreactive T-cells to RE in peripheral blood samples from patients with latent TB-associated uveitis or sarcoid uveitis. Although the absence of circulating retina-specific autoreactive T-cells cannot be ruled out, we propose that the number of such cells is far too low for reliable detection, even here with the use of highly sensitive flowcytometric approach. To determine the presumed pathophysiological role of autoimmune reactions in active and inactive TB-associated uveitis, as well as sarcoid uveitis, intraocular fluid samples should be examined. 
